These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 38476610)

  • 21. Endosialin-positive tumor-derived pericytes promote tumor progression through impeding the infiltration of CD8
    Lu T; Zhang J; Lu S; Yang F; Gan L; Wu X; Song H; Liu S; Xu C; Han D; Yang B; Wen W; Qin W; Yang L
    Cancer Immunol Immunother; 2023 Jun; 72(6):1739-1750. PubMed ID: 36646951
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immune-related long non-coding RNAs can serve as prognostic biomarkers for clear cell renal cell carcinoma.
    Li CS; Lu ZZ; Fang DL; Zhou WJ; Wei J
    Transl Androl Urol; 2021 Jun; 10(6):2478-2492. PubMed ID: 34295734
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LINC00887 Fosters Development of Clear Cell Renal Cell Carcinoma via Inhibiting CD8+ T Cell Immune Infiltration.
    Wu J; Lin R; Zhang L; Wei Y; Zhang R; Cai W; Hu W
    Comput Math Methods Med; 2022; 2022():2582474. PubMed ID: 36060659
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Wiskott-Aldrich syndrome gene as a prognostic biomarker correlated with immune infiltrates in clear cell renal cell carcinoma.
    Ding G; Wang T; Liu S; Zhou Z; Ma J; Wu J
    Front Immunol; 2023; 14():1102824. PubMed ID: 37122750
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MiR-224 Executes a Tumor Accelerative Role during Hepatocellular Carcinoma Malignancy by Targeting Cytoplasmic Polyadenylation Element-Binding Protein 3.
    Miao K; Liu SD; Huang WX; Dong H
    Pharmacology; 2020; 105(7-8):477-487. PubMed ID: 32454494
    [TBL] [Abstract][Full Text] [Related]  

  • 26. KL is a favorable prognostic factor related immune for clear cell renal cell carcinoma.
    Pan KH; Yao L; Chen Z; Sun J; Jia Z; Zhang J; Ling Z
    Eur J Med Res; 2023 Sep; 28(1):356. PubMed ID: 37726833
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identify AGAP2 as prognostic biomarker in clear cell renal cell carcinoma based on bioinformatics and IHC staining.
    Xu Z; Wang Y; Xu J; Ang X; Ge N; Xu M; Pei C
    Heliyon; 2023 Feb; 9(2):e13543. PubMed ID: 36846683
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of the prognostic value of
    Chen J; Ye Z; Liu L; Xuan B
    Transl Androl Urol; 2022 Apr; 11(4):509-518. PubMed ID: 35558273
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LZTS2: A novel and independent prognostic biomarker for clear cell renal cell carcinoma.
    Peng Y; Greenland NY; Lang UE; Stohr BA
    Pathol Res Pract; 2022 Apr; 232():153831. PubMed ID: 35287088
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intratumoral CXCL13
    Dai S; Zeng H; Liu Z; Jin K; Jiang W; Wang Z; Lin Z; Xiong Y; Wang J; Chang Y; Bai Q; Xia Y; Liu L; Zhu Y; Xu L; Qu Y; Guo J; Xu J
    J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33589528
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High Hepcidin expression predicts poor prognosis in patients with clear cell renal cell carcinoma.
    Tang Y; Ge S; Zheng X; Zheng J
    Diagn Pathol; 2022 Dec; 17(1):100. PubMed ID: 36585741
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
    Rabjerg M
    Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic significance and tumor-immune infiltration of mTOR in clear cell renal cell carcinoma.
    Li N; Chen J; Liu Q; Qu H; Yang X; Gao P; Wang Y; Gao H; Wang H; Zhao Z
    PeerJ; 2021; 9():e11901. PubMed ID: 34458019
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic value of sirtuin family members and experimental verification identify SIRT5 as diagnostic biomarkers in clear cell renal cell carcinoma.
    Peng LS; Duan SL; Li RQ; Bai ZY; Ou CL; Wang JP
    PeerJ; 2023; 11():e15154. PubMed ID: 37096064
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comprehensive analysis of the prognostic value and immune infiltration of low expression DBT in clear cell renal cell carcinoma.
    Xie W; Xi P; Liu Y; Zhang Z; Sun T
    Front Pharmacol; 2022; 13():1002588. PubMed ID: 36299888
    [No Abstract]   [Full Text] [Related]  

  • 36. Upregulation of ARNTL2 is associated with poor survival and immune infiltration in clear cell renal cell carcinoma.
    Wang S; Ma X; Ying Y; Sun J; Yang Z; Li J; Jin K; Wang X; Xie B; Zheng X; Liu B; Xie L
    Cancer Cell Int; 2021 Jul; 21(1):341. PubMed ID: 34217271
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IGFLR1 as a Novel Prognostic Biomarker in Clear Cell Renal Cell Cancer Correlating With Immune Infiltrates.
    Song W; Shao Y; He X; Gong P; Yang Y; Huang S; Zeng Y; Wei L; Zhang J
    Front Mol Biosci; 2020; 7():565173. PubMed ID: 33324675
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unraveling the prognostic significance and molecular characteristics of tumor-infiltrating B lymphocytes in clear cell renal cell carcinoma through a comprehensive bioinformatics analysis.
    Yue Y; Cai X; Lu C; Sechi LA; Solla P; Li S
    Front Immunol; 2023; 14():1238312. PubMed ID: 37908350
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GBP2 serves as a novel prognostic biomarker and potential immune microenvironment indicator in renal cell carcinoma.
    Tian Y; Wang H; Guan W; Tu X; Zhang X; Sun Y; Qian C; Song X; Peng B; Cui X
    Mol Carcinog; 2022 Dec; 61(12):1082-1098. PubMed ID: 36222186
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Accumulation of CD45RO+CD8+ T cells is a diagnostic and prognostic biomarker for clear cell renal cell carcinoma.
    Wu K; Zheng X; Yao Z; Zheng Z; Huang W; Mu X; Sun F; Liu Z; Zheng J
    Aging (Albany NY); 2021 May; 13(10):14304-14321. PubMed ID: 34016791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.